Insights into growth capital, buyouts and follow-on mergers and acquisitions (M&A).
This is exclusive item - please log in or subscribe to view this item.
With an £18m investment from LDC, the future is looking healthy for innovative drug development company TMC. David Prosser learns of plans for international expansion
This is exclusive item - please log in or subscribe to view this item.
With private equity looking for quality assets, a management team that has been there, done that and got the T-shirt is very appealing. Jason Sinclair looks at how Gresham House Ventures and BGF teamed up to invest in Panthera Biopartners.
This is exclusive item - please log in or subscribe to view this item.
Is too much venture capital chasing too little return? Has too much enthusiasm led to a bubble? Jon Moulton reflects on an excess of investor cash looking for a home
This is exclusive item - please log in or subscribe to view this item.
Mobeus Equity Partners’ investment in telesales company Gungho Marketing was really all about pulling together. David Prosser speaks to the investor and its advisers on the management buy-out
This is exclusive item - please log in or subscribe to view this item.
As we enter a tougher economic period, Jason Sinclair looks at the past five and a half years of deal activity as we profile the 10 firms completing the most mid-market deals.
This is exclusive item - please log in or subscribe to view this item.
ESG has arguably been the most talked-about topic in private equity – publicly, at least – says Andrew Green, a corporate partner at Addleshaw Goddard. But what is being said and what does it mean in the buy-out world?
This is exclusive item - please log in or subscribe to view this item.
Lisa Wootton, PwC director, explains that with private equity in intense competition for prized assets, there is ever-increasing adoption of a more bespoke approach.
This is exclusive item - please log in or subscribe to view this item.
Jon Moulton argues that the idea that big buy-out funds can keep growing doesn’t make sense. But then again, he thought that 10 years ago, too.
This is exclusive item - please log in or subscribe to view this item.
Matching an investor’s USP with a management team’s priorities was a big challenge, says Claire Davis, partner at LAVA Advisory Partners.
A degree of inflation is welcome, says Jon Moulton. He explains how it can be a friend to dealmakers rather than an enemy.